公开(公告)号：US11783931B2

公开(公告)日：2023-10-10

申请号：US17119011

申请日：2020-12-11

Applicant: TAKEDA PHARMACEUTICAL COMPANY LIMITED

Inventor： Gerald Spotts ,  Roman Pichler ,  Michael Nelson

IPC: G16H20/10 ,  G16C20/30 ,  G09C5/00 ,  G16H50/30 ,  G16H50/50 ,  G06N7/01 ,  G16H10/60 ,  H04L9/06 ,  G16B50/00 ,  G16B40/00 ,  G16C20/90

CPC classification number: G16H20/10 ,  G06N7/01 ,  G09C5/00 ,  G16C20/30 ,  G16H10/60 ,  G16H50/30 ,  G16H50/50 ,  H04L9/0637 ,  G16B40/00 ,  G16B50/00 ,  G16C20/90

Abstract: A drug monitoring tool comprises a data receiver and an interactive user interface. The data receiver is configured to receive a pharmacokinetic (PK) profile of a patient. The interactive user interface is configured to display, to the patient, a time-varying therapeutic plasma protein level of the patient and delineate a plurality of zones within the interactive user interface associated with the time-varying therapeutic plasma protein level. The plurality of zones includes a safe zone indicating to the patient that the time-varying therapeutic plasma protein level is within a first concentration range considered safe for physical activity and a danger zone indicating to the patient that the time-varying therapeutic plasma protein level is within a second concentration range and physical activity should be limited.